Spravato® (Esketamine) for Treatment-Resistant Depression in Scottsdale, AZ

FDA-approved Spravato® (esketamine) nasal spray is administered in our certified Scottsdale office under direct medical supervision — for adults whose depression hasn't responded to standard antidepressants.

Spravato® Treatment for Adults & Veterans

What Is Spravato®?

Spravato® (esketamine) is an FDA-approved prescription medication for adults with treatment-resistant depression. It is administered as a nasal spray in a certified medical setting under direct supervision. Spravato works differently than traditional antidepressants and is used in conjunction with an oral antidepressant, as part of a structured treatment program. At Sonoran Sun Wellness, Spravato is offered within a comprehensive psychiatric framework to ensure safety, appropriateness, and coordinated care.

What Is Spravato®?

Spravato (esketamine) is an FDA-approved prescription treatment for adults with treatment-resistant depression (TRD) — defined as inadequate response to at least two antidepressant trials of adequate dose and duration. Unlike traditional antidepressants that take weeks to build up in your system, Spravato targets the brain's glutamate system and many patients experience meaningful improvement within days.

Spravato is a nasal spray administered in a certified clinical setting. Patients self-administer the spray under medical supervision, remain monitored in our office for a minimum of two hours following each dose, and arrange transportation home. It is used alongside an oral antidepressant as part of a structured treatment protocol.

Who May Be a Candidate for Spravato?

A psychiatric evaluation with our team will determine whether Spravato is clinically appropriate for you. Generally, candidates are adults who have tried at least two antidepressant medications without adequate relief, are currently under the care of a psychiatric provider, and are able to participate in supervised in-office treatment sessions.

We serve veterans through TRICARE and VA coverage, and many commercial insurance plans cover Spravato for qualifying patients. Our team verifies your benefits before treatment begins.

The Spravato Treatment Protocol

Induction phase: Twice-weekly sessions for the first 4 weeks
Maintenance phase: Once-weekly for weeks 5–8, then twice monthly as clinically indicated
Each session lasts approximately 2 hours in our Scottsdale office
Patient must arrange transportation — no driving after sessions
Coordinated with oral antidepressant and ongoing psychiatric follow-up

Spravato Within Integrated Care

Spravato at Sonoran Sun Wellness is always provided within a comprehensive psychiatric framework — including monitoring, therapy coordination, medication management, and outcome tracking. We don't offer Spravato as a standalone service because we've seen the difference integrated care makes in sustained recovery.